Daniel Hsiang-Te Tsai

21PUBLICATIONS
62CO-AUTHORS
Epidemiological modellingHaematological tumoursMedical biochemistry - lipidsPharmacogenomicsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 07, 2026
SGLT2 Inhibitors and Asthma Exacerbation Risk Among Patients With Type 2 Diabetes and Asthma: A Target Trial Emulation.

|Apr 22, 2026
Comparison of adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema: A global network study.

|Apr 01, 2026
Hyperuricemia risk in bempedoic acid-treated hyperlipidemic patients.

Po-Hsueh Su, Daniel Hsiang-Te Tsai, Miyuki Hsing-Chun Hsieh

|Mar 06, 2026
SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation.

Shih-Chieh Shao, Daniel Hsiang-Te Tsai, Albert Tzu-Ming Chuang

|Jan 20, 2026
Intraocular inflammation incidence and real-world safety of intravitreal faricimab treatment across retinal indications.

Wan-Ju Annabelle Lee, Daniel Hsiang-Te Tsai, Shih-Chieh Shao

|Dec 01, 2025
Taiwan's National Health Insurance Research Database (NHIRD): in the Era of Artificial Intelligence, Causal Inference, and Data Security.

Cheng-Yang Hsieh, Shih-Chieh Shao, Sheng-Feng Sung

Pageof 4

Frequent Collaborators

16 joint publications

Edward Chia-Cheng Lai

9 joint publications

Shih-Chieh Shao

5 joint publications

Avery Shuei-He Yang

3 joint publications

Michael Chun-Yuan Cheng